Pharmafile Logo
Pharmafocus logo
Advanced Search

sovaldi

Showing 15 posts of 55 posts found.

BMS image

BMS pulls hep C combo treatment in US

October 7, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BMS, Combo, HCV, asunaprevir, daclatasvir, hep C, sovaldi

Bristol-Myers Squibb will not attempt to bring its new combination hepatitis C treatment to the US market given the current …

News
Sovaldi pack shot

Sovaldi ‘unaffordable’ says NHS documents

October 7, 2014
Medical Communications, Research and Development, Sales and Marketing NHS England, fund, hep C, sovaldi

Senior health officials may have to bar Gilead’s new hepatitis C pill Sovaldi from being funded on the NHS after …

News
J&J image

J&J bets $1.75 billion on virology

October 1, 2014
Research and Development, Sales and Marketing AL-8176, Alios BioPharma, J&J, JJ, Janssen, sovaldi, viral

Johnson & Johnson has signed a deal to acquire Alios BioPharma, a privately-held company focussed on developing therapies for viral …

News

Sovaldi combo sees CHMP green light

September 29, 2014
Sales and Marketing CHMP, EU, Gilead, HCV, harvoni, hep C, sovaldi

The CHMP is recommending that Gilead’s new combination hepatitis C drug therapy Harvoni should be approved for use across the …

News
Sovaldi image

Gilead allows generic prices for Sovaldi

September 16, 2014
Manufacturing and Production, Sales and Marketing Gilead, hep C, hepatitis C, sofosbuvir, sovaldi

Gilead will allow Indian generic drug firms to make cheap copies of its new hepatitis C pill Sovaldi in an …

News
david_cameron

Government rips up blank cheque on cancer drugs

August 28, 2014
Medical Communications, Sales and Marketing Cancer Drugs Fund, Kadclya, Roche, avastin, sovaldi

Pharma has priced itself out of the Cancer Drugs Fund as the rising costs of its new oncology treatments sees …

News
Incivek image

Vertex ditches its once-stellar hep C drug

August 14, 2014
Sales and Marketing Gilead, Incivek, Vertex, hep C, sovaldi

Vertex will stop selling its once-blockbuster hepatitis C drug in the US this autumn after being crushed by new therapies. …

News
sovaldi_ariad_sofosbuvir_bottle_1

NHS England’s Sovaldi fund: opening the floodgates?

July 26, 2014
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CDG, NICE, Professor David Haslam, hep C, sovaldi

Whilst seemingly more and more barriers are being erected to slow down the adoption of new medicines, there is a …

Feature
Gilead image

FDA approves Gilead’s blood cancer drug

July 24, 2014
Research and Development, Sales and Marketing Cancer, FDA, Gilead, blood, follicular lymphoma and small lymphocytic lymphoma, lymphocytic leukaemia, sovaldi, zydelig

The Food and Drug Administration has approved Gilead Sciences new treatment Zydelig (idelalisib) to treat three types of blood cancer.  …

News
Sovaldi (sofosbuvir) image

Sovaldi scores in HIV patients

July 21, 2014
Sales and Marketing Gilead, HIV, JAMA, hep C, hepatitis C, sovaldi

Patients with HIV and hepatitis C virus (HCV) have responded well to a combination of Gilead Sciences’ Sovaldi and ribavirin …

News
jj_building_0

New drugs see J&J sales rise

July 17, 2014
Medical Communications, Sales and Marketing J&J, JJ, Q2, hepatitis C, olysio, sovaldi

Johnson & Johnson saw sales rise 9.1% to $19.5 billion year on year on the back of a strong performance …

News
Abbvie image

AbbVie hep C treatment fast-tracked

June 18, 2014
Research and Development, Sales and Marketing AbbVie, Abbott, EMA, EU, Gilead, HCV, hep C, sovaldi

The European regulator is to fast-track AbbVie’s oral, interferon-free treatment for adults with chronic genotype 1 (GT1) hepatitis C virus …

News
gilead_-sciences

NICE rejection looms for Sovaldi

June 16, 2014
Sales and Marketing Gilead, NHS, NICE, SMC, hep C, sofosbuvir, sovaldi

In a draft recommendation published today NICE is asking Gilead for more information on its new hepatitis C pill Sovaldi …

News
Sovaldi image

Sovaldi hurdles first drug pricing barrier

June 10, 2014
Sales and Marketing Gilead, SMC, Scotland, hep C, sofosbuvir, sovaldi

Scotland’s NHS will pay for Gilead’s new hepatitis C pill Sovaldi despite rising concern over its high cost. The Scottish …

News

Sales forecasts leave Sovaldi top and Januvia lagging

May 23, 2014
Sales and Marketing Gilead, Januvia, Merck, diabetes, ep, hep C, sovaldi

Sovaldi has topped analysts’ estimates for future growth but Merck’s big-selling diabetes drug Januvia is falling by the wayside. This …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025